Large scale tests have indicated that Gerovital H3 helps people with:
Large scale tests have indicated that Gerovital H3 helps people with:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wrinkles |
Test results of 15 000 peoples for two years: One group taking Gerovital H3 The other control group not:
Blood pressure was improved in 85% with Gerovital; control group, 63.8%.
Heart problems were improved in 85.2% with Gerovitalcontrol group, 63.8%
High pulse rate was normalized in 93% of the Gerovital group, control group, 88%.
Low pulse rate was normalized in 9% more of the GH3 treated patients.
Respiratory capacity was unchanged in 96.1% of the Gerovital patients as opposed to 91.2% in the control group. This is significant because lung capacity decreases rapidly during the late, middle years. Stabilizing lung capacity in patients of these ages implies a retardation of the aging process.
Cardiovascular effect of those showing a low heart rate. Gerovital maintained most patients at the same level for two years when a slow decline would be normally expected.
Muscular strength there were significant improvements in twice as many of the Gerovital patients than the control group. 25.9% showed improvement with Gerovital when a decline of muscle power is expected.
Work absences diminished 40% with the GH3 patients. Also 77% of the GH3 group performed their work production norms, whereas 20% actually exceeded their usual work performance.